Qatar News Agency | QNA Latest Updates

Qatar Red crescent Launches Critical Cancer Treatment Project in Syria

Providing vital chemotherapy, immunotherapy, and hormone medicine to patients in northern Syria, the initiative aims to alleviate suffering and reduce mortality rates amidst ongoing healthcare challenges.

Doha, Qatar – The Qatar Red Crescent Society (QRCS) has initiated a new five-month project to deliver essential cancer medications to patients receiving treatment at oncology centers in northern Syria. The effort addresses a critical gap in specialized healthcare access,exacerbated by the ongoing conflict and the prohibitive cost of cancer treatment.

Addressing a Critical Healthcare Gap

Meaningful deficiencies in specialized healthcare services plague northern Syria, a situation worsened by the protracted conflict and the financial burden of cancer medication. According to a statement released on Sunday, the QRCS project is designed to directly combat rising mortality rates and reduce the severity of health complications experienced by cancer patients. A key objective is to lessen the strain on local health facilities by minimizing the need to transfer patients abroad for treatment.

The project focuses on the delivery and distribution of crucial drugs used in cancer treatment. QRCS anticipates that 112 cancer patients will directly benefit from the initiative over the next five months, with an additional 560 individuals – family members and members of the local community – experiencing indirect benefits.

Did you know? – Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, according to the World Health Organization. Access to treatment is often limited in conflict zones.

Collaboration with International Health Organizations

The delivery, distribution, and verification of these vital medications are being conducted in close coordination with the World Health Organization (WHO) and local health authorities in idlib and Aleppo. The medications provided include both chemotherapy and immunotherapy drugs, ensuring a thorough approach to patient care.

“In view of the high mortality rates and limited resources, there is still a need for more support to avoid this gap and offer early identification and treatment services for diffrent types of cancer,” stated a senior official at QRCS.

Expanding Support for Syrian Cancer Patients

QRCS is already preparing for a follow-up project aimed at providing chemotherapy and immunotherapy to 400 additional displaced and impoverished cancer patients in Syrian oncology centers.The organization emphasized the profound impact even modest donations can have, noting that a contribution of just 10,000 Qatari Riyal can potentially save the life of a patient battling cancer for years.

This latest initiative builds upon previous QRCS efforts in 2024,which provided medication and medical supplies to over 900 cancer patients. That earlier project also included support for cancer treatment centers through the provision of medical equipment and training for healthcare personnel.

Pro tip: – Supporting organizations like QRCS allows for efficient delivery of aid. Donations are frequently enough pooled to maximize impact and reach more patients in need.

The QRCS’s continued commitment to providing cancer care in Syria underscores the urgent need for sustained humanitarian assistance in the region.

Why: The Qatar Red Crescent Society (QRCS) launched a five-month project to address a critical gap in cancer care in northern Syria, where specialized healthcare is severely lacking due to ongoing conflict and financial constraints. Rising mortality rates and the high cost of treatment prompted the initiative.

Who: The QRCS is the primary organization leading the effort, in close coordination with the World Health Organization (WHO) and local health authorities in idlib and Aleppo. The project directly benefits 112 cancer patients and indirectly supports approximately 560 family members and community members.

What: The project focuses on delivering and distributing essential cancer medications – chemotherapy, immunotherapy, and hormone medicine – to oncology centers in northern Syria. it also includes providing medical equipment and training for healthcare personnel, building on previous efforts.How did it end? The initial five-month project is underway, aiming to treat 112 patients. QRCS is already planning a follow-up project to extend care to 400 additional patients. The organization highlights the potential for even small